In recent trading session, Elevance Health Inc (NYSE:ELV) saw 2.83 million shares changing hands at last check today with its beta currently measuring 0.61. Company’s recent per share price level of $309.1 trading at -$35.45 or -10.29% at last check today assigns it a market valuation of $69.84B. That most recent trading price of ELV’s stock is at a discount of -83.52% from its 52-week high price of $567.26 and is indicating a discount of -8.43% from its 52-week low price of $335.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.15 million shares which gives us an average trading volume of 1.81 million if we extend that period to 3-months.
For Elevance Health Inc (ELV), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 12 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 11 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Elevance Health Inc (NYSE:ELV) trade information
Upright in the red during last session for losing -10.29%, in the last five days ELV remained trading in the red while hitting it’s week-highest on Wednesday, 07/16/25 when the stock touched $309.1 price level, adding 10.76% to its value on the day. Elevance Health Inc’s shares saw a change of -41.75% in year-to-date performance and have moved -10.63% in past 5-day. Elevance Health Inc (NYSE:ELV) showed a performance of -17.91% in past 30-days. Number of shares sold short was 2.5 million shares which calculate 1.29 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 482.5 to the stock, which implies a rise of 35.94% to its recent value today. Analysts have been projecting 465 as a low price target for the stock while placing it at a high target of 500. It follows that stock’s current price would drop -50.44% in reaching the projected high whereas dropping to the targeted low would mean a loss of -50.44% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 6.81% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 3.32% while estimates for its earnings growth in next 5 years are of 9.58%.
ELV Dividends
Elevance Health Inc is more likely to be releasing its next quarterly report on 2025-Apr-22 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 2.16%, the share has a forward dividend of 6.68 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 1.2%.
Elevance Health Inc (NYSE:ELV)’s Major holders
Insiders are in possession of 0.17% of company’s total shares while institution are holding 93.07 percent of that, with stock having share float percentage of 93.23%. Investors also watch the number of corporate investors in a company very closely, which is 93.07% institutions for Elevance Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at ELV for having 21.21 million shares of worth $11.49 billion. And as of 2024-06-30, it was holding 9.133 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 20.7 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.9168 of outstanding shares, having a total worth of $11.22 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 7.06 shares of worth $2.17 billion or 3.12% of the total outstanding shares. The later fund manager was in possession of 6.32 shares on Mar 31, 2025 , making its stake of worth around $1.95 billion in the company or a holder of 2.80% of company’s stock.
